Works matching Multiple sclerosis treatment

Results: 5000

Treatment of Secondary Progressive Multiple Sclerosis: Current Recommendations and Future Prospects.

Published in:

BioDrugs, 1999, v. 12, n. 4, p. 267, doi. 10.2165/00063030-199912040-00004

By:

Rice, G.P.A.

Publication type:

Article

Early-Stage Multiple Sclerosis: What Are the Treatment Options?

Published in:

Drugs, 2004, v. 64, n. 18, p. 2021, doi. 10.2165/00003495-200464180-00002

By:

Sorensen, Per Soelberg

Publication type:

Article

Localized Panniculitis and Subsequent Lipoatrophy with Subcutaneous Glatiramer Acetate (Copaxone<sup>®</sup>) Injection for the Treatment of Multiple Sclerosis.

Published in:

American Journal of Clinical Dermatology, 2004, v. 5, n. 5, p. 357, doi. 10.2165/00128071-200405050-00009

By:

Soós, Noemi;
Shakery, Kaweh;
Mrowietz, Ulrich

Publication type:

Article

Disease Modifying Treatments for Multiple Sclerosis: What is on the Horizon?

Published in:

CNS Drugs, 1999, v. 11, n. 2, p. 133, doi. 10.2165/00023210-199911020-00005

By:

Weilbach, F.X.;
Gold, R.

Publication type:

Article

Agresyvios eigos recidyvuojančios remituojančios išsėtinės sklerozės gydymas natalizumabu.

Published in:

Neurologijos Seminarai, 2012, v. 16, n. 4, p. 289

By:

Aleknaitė, L.;
Kizlaitienė, R.;
Kaubrys, G.;
Budrys, V.

Publication type:

Article

Treatment of Multiple Sclerosis with the Interferon-βs: Comparative Risks and Benefits.

Published in:

BioDrugs, 1998, v. 10, n. 6, p. 463, doi. 10.2165/00063030-199810060-00004

By:

Herndon, R.M.

Publication type:

Article

What is New in the Treatment of Multiple Sclerosis?

Published in:

Drugs, 2000, v. 59, n. 3, p. 401, doi. 10.2165/00003495-200059030-00002

By:

Weinstock-Guttman, B.;
Jacobs, L.D.

Publication type:

Article

Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis.

Published in:

2018

By:

Riordan, Neil H.;
Morales, Isabela;
Fernández, Giselle;
Allen, Nicole;
Fearnot, Neal E.;
Leckrone, Michael E.;
Markovich, Dedra Jones;
Mansfield, Darla;
Avila, Dorita;
Patel, Amit N.;
Kesari, Santosh;
Paz Rodriguez, Jorge;
Fernández, Giselle

Publication type:

journal article

Long-term treatment of multiple sclerosis with interferon-beta may be cost effective.

Published in:

2000

By:

Kendrick, M.;
Johnson, K.I.

Publication type:

journal article

Combination therapy for multiple sclerosis: the treatment strategy of the future?

Published in:

2004

By:

Weinstock-Guttman, Bianca;
Bakshi, Rohit

Publication type:

journal article

2014 Joint Americas Committee for Treatment and Research in Multiple Sclerosis-European Committee for Treatment and Research in Multiple Sclerosis Meeting.

Published in:

Clinical & Experimental Neuroimmunology, 2015, v. 6, n. 1, p. 100, doi. 10.1111/cen3.12171

By:

Sato, Douglas Kazutoshi

Publication type:

Article

Congress report of the sixth triennial joint Americas Committee for Treatment and Research in Multiple Sclerosis-European Committee for Treatment and Research in Multiple Sclerosis meeting in Boston.

Published in:

Clinical & Experimental Neuroimmunology, 2015, v. 6, n. 1, p. 103, doi. 10.1111/cen3.12176

By:

Takata, Kazushiro

Publication type:

Article

Clinical Roundup: Selected Treatment Options for Multiple Sclerosis—Part 2.

Published in:: Alternative & Complementary Therapies, 2019, v. 25, n. 5, p. 269, doi. 10.1089/act.2019.29236.cru
Publication type:: Article

Current issues in immunomodulatory treatment of multiple sclerosis: A practical approach.

Published in:

Journal of Neurology, 2006, v. 253, p. I32, doi. 10.1007/s00415-006-1108-9

By:

Stangel, Martin;
Gold, Ralf;
Gass, Achim;
Haas, Judith;
Jung, Stefan;
Elias, Wolfgang;
Uwe K. Zettl

Publication type:

Article

European and American Guidelines for Multiple Sclerosis Treatment.

Published in:

Neurology & Therapy, 2018, v. 7, n. 2, p. 189, doi. 10.1007/s40120-018-0112-1

By:

Ghezzi, Angelo

Publication type:

Article

Two decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing-remitting multiple sclerosis treatment.

Published in:

Patient Preference & Adherence, 2014, v. 8, p. 1123, doi. 10.2147/PPA.S68698

By:

Caporro, Matteo;
Disanto, Giulio;
Gobbi, Claudio;
Zecca, Chiara

Publication type:

Article

Alemtuzumab: a review of efficacy and risks in the treatment of relapsing remitting multiple sclerosis.

Published in:

2017

By:

Guarnera, Cristina;
Bramanti, Placido;
Mazzon, Emanuela

Publication type:

journal article

Primary Progressive Multiple Sclerosis Under Anti-TNFα Treatment: A Case Report.

Published in:

Journal of Central Nervous System Disease, 2020, p. 1, doi. 10.1177/1179573520973820

By:

Iovino, Aniello;
Aruta, Francesco;
Dubbioso, Raffaele;
Ruggiero, Lucia;
Tozza, Stefano;
Spina, Emanuele;
Manganelli, Fiore;
Iodice, Rosa

Publication type:

Article

The IMCO Scheme as a Tool in Developing Team-Based Treatment for People with Multiple Sclerosis.

Published in:

Journal of Alternative & Complementary Medicine, 2008, v. 14, n. 1, p. 69, doi. 10.1089/acm.2007.0593

By:

Launsø, Laila;
Skovgaard, Lasse

Publication type:

Article

The long-term impact of early treatment of multiple sclerosis on the risk of disability pension.

Published in:

Journal of Neurology, 2018, v. 265, n. 3, p. 701, doi. 10.1007/s00415-018-8764-4

By:

Landfeldt, Erik;
Castelo-Branco, Anna;
Svedbom, Axel;
Löfroth, Emil;
Kavaliunas, Andrius;
Hillert, Jan

Publication type:

Article

Natalizumab treatment of multiple sclerosis in Spain: results of an extensive observational study.

Published in:

Journal of Neurology, 2012, v. 259, n. 9, p. 1814, doi. 10.1007/s00415-012-6414-9

By:

Fernández, O.;
Oreja-Guevara, C.;
Arroyo, R.;
Izquierdo, G.;
Pérez, J.;
Montalban, X.

Publication type:

Article

A regenerative approach to the treatment of multiple sclerosis.

Published in:

Nature, 2013, v. 502, n. 7471, p. 327, doi. 10.1038/nature12647

By:

Deshmukh, Vishal A.;
Tardif, Virginie;
Lyssiotis, Costas A.;
Green, Chelsea C.;
Kerman, Bilal;
Kim, Hyung Joon;
Padmanabhan, Krishnan;
Swoboda, Jonathan G.;
Ahmad, Insha;
Kondo, Toru;
Gage, Fred H.;
Theofilopoulos, Argyrios N.;
Lawson, Brian R.;
Schultz, Peter G.;
Lairson, Luke L.

Publication type:

Article

Multiple sclerosis: Closing in on an oral treatment.

Published in:

Nature, 2010, v. 464, n. 7287, p. 360, doi. 10.1038/464360a

By:

Martin, Roland

Publication type:

Article

Systematic review of the association between interferon treatment and depression in patients with multiple sclerosis.

Published in:

European Psychiatry, 2016, v. 33, p. S179, doi. 10.1016/j.eurpsy.2016.01.307

By:

Alba Palé, L.;
Samsó Buxareu, B.;
León Caballero, J.;
Chavarria Romero, V.;
Pérez Sánchez, E.J.;
Palma Conesa, A.J.;
Ginés Miranda, J.M.;
Salgado Serrano, P.;
Perez Sola, V.

Publication type:

Article

A REVIEW ON ADVANCEMENTS IN MULTIPLE SCLEROSIS AND ITS TREATMENT.

Published in:

Journal of Advanced Scientific Research, 2020, v. 11, n. 2, p. 10

By:

Bhuvaneswari, Mylipilli;
Prabhakar, Orsu;
Arun, Koyyada

Publication type:

Article

The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group.

Published in:

Multiple Sclerosis (13524585), 2010, v. 16, n. 4, p. 503, doi. 10.1177/1352458509359727

By:

Freedman, Mark S.;
Bar-Or, Amit;
Atkins, Harold L.;
Karussis, Dimitrios;
Frassoni, Francesco;
Lazarus, Hillard;
Scolding, Neil;
Slavin, Shimon;
Le Blanc, Katarina;
Uccelli, Antonio

Publication type:

Article

Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode.

Published in:

Multiple Sclerosis (13524585), 2009, v. 15, n. 10, p. 1175, doi. 10.1177/1352458509107007

By:

Goodin, D. S.;
Bates, D.

Publication type:

Article

Multiple sclerosis: effect of beta interferon treatment on survival.

Published in:

2019

By:

Kingwell, Elaine;
Leray, Emmanuelle;
Zhu, Feng;
Petkau, John;
Edan, Gilles;
Oger, Joel;
Tremlett, Helen

Publication type:

journal article

Course of therapy in patients with active relapsing-remitting multiple sclerosis despite first-line treatment.

Published in:

Postepy Psychiatrii i Neurologii / Advances in Psychiatry & Neurology, 2023, v. 32, n. 2, p. 59, doi. 10.5114/ppn.2023.129048

By:

Bartosik-Psujek, Halina;
Adamczyk-Sowa, Monika;
Kułakowska, Alina;
Głażewska, Joanna;
Smaga, Anna;
Brola, Waldemar

Publication type:

Article

Bruton's tyrosine kinase inhibitors in the treatment of multiple sclerosis.

Published in:

Postepy Psychiatrii i Neurologii / Advances in Psychiatry & Neurology, 2023, v. 32, n. 1, p. 23, doi. 10.5114/ppn.2023.126319

By:

Shulga, Olga;
Chabanova, Anna;
Kotsiuba, Oleksandra

Publication type:

Article

Immune parameters of patients treated with laquinimod, a novel oral therapy for the treatment of multiple sclerosis: results from a double-blind placebo-controlled study.

Published in:

Immunity, Inflammation & Disease, 2015, v. 3, n. 2, p. 45, doi. 10.1002/iid3.42

By:

Stasiolek, Mariusz;
Linker, Ralf A.;
Hayardeny, Liat;
Bar Ilan, Oren;
Gold, Ralf

Publication type:

Article

Progress in the diagnosis and treatment of multiple sclerosis.

Published in:

Chinese Journal of Contemporary Neurology & Neurosurgery, 2014, v. 14, n. 10, p. 849, doi. 10.3969/j.issn.1672-6731.2014.10.004

By:

HOU Shi-fang;
LIU Yin-hong;
XU Xian-hao

Publication type:

Article

Clinical Roundup: Selected Treatment Options for Multiple Sclerosis—Part 1.

Published in:: Alternative & Complementary Therapies, 2019, v. 25, n. 4, p. 222, doi. 10.1089/act.2019.29232.cru
Publication type:: Article

Türkiye'de Mııltipl Skleroz Hastalığının Tanı ve Tedavisine Genel Yaklaşım.

Published in:

Turkish Journal of Neurology / Turk Noroloji Dergisi, 2009, v. 15, n. 3, p. 124

By:

Terzi, Murat;
Çelik, Yahya;
Kilinç, Münire;
Seleker, Feray;
Iflik, Nihal;
Gedizlioğlu, Muhteflem;
Zorlu, Yaflar

Publication type:

Article

The Remarkable Story of Copaxone<sup>®</sup>: An Approach to the Treatment of Multiple Sclerosis.

Published in:

2011

By:

Jellinger, K. A.

Publication type:

Book Review

A retrospective, observational study comparing the four available immunomodulatory treatments for relapsing–remitting multiple sclerosis.

Published in:

European Journal of Neurology, 2003, v. 10, n. 6, p. 671, doi. 10.1046/j.1468-1331.2003.00669.x

By:

Carra, A.;
Onaha, P.;
Sinay, V.;
Alvarez, F.;
Luetic, G.;
Bettinelli, R.;
San Pedro, E.;
Rodriguez, L.

Publication type:

Article

Neutralizing and binding anti-interferon-β (IFN-β) antibodies. A comparison between IFN-β-1a and IFN-β-1b treatment in multiple sclerosis.

Published in:

European Journal of Neurology, 2000, v. 7, n. 1, p. 27, doi. 10.1046/j.1468-1331.2000.00002.x

By:

Kivisäkk, P.;
Alm, G. V.;
Fredrikson, S.;
Link, H.

Publication type:

Article

Plasma protein profiling reveals candidate biomarkers for multiple sclerosis treatment.

Published in:

PLoS ONE, 2019, v. 14, n. 5, p. 1, doi. 10.1371/journal.pone.0217208

By:

Bedri, Sahl Khalid;
Nilsson, Ola B.;
Fink, Katharina;
Månberg, Anna;
Hamsten, Carl;
Ayoglu, Burcu;
Manouchehrinia, Ali;
Nilsson, Peter;
Olsson, Tomas;
Hillert, Jan;
Grönlund, Hans;
Glaser, Anna

Publication type:

Article

Real-world study of efficacy, risk management and reasons for discontinuation of natalizumab for treatment of multiple sclerosis in Russia.

Published in:

PLoS ONE, 2019, v. 14, n. 5, p. 1, doi. 10.1371/journal.pone.0217303

By:

Evdoshenko, Evgeniy;
Stepanova, Alexandra;
Shumilina, Maria;
Davydovskaya, Maria;
Khachanova, Natalia;
Neofidov, Nikolay;
Kalinin, Ivan;
Popova, Ekaterina;
Dubchenko, Ekaterina;
Pozhidaeva, Natalia;
Volkov, Andrey;
Sivertseva, Stella;
Prilenskaya, Anna;
Malkova, Nadezhda;
Korobko, Denis;
Vergunova, Ilona;
Shchur, Sergey;
Makshakov, Gleb

Publication type:

Article

Alemtuzumab may be a new, superior treatment for relapsing multiple sclerosis.

Published in:

Expert Review of Clinical Immunology, 2013, v. 9, n. 1, p. 9

By:

Patience, Jonny

Publication type:

Article

Multiple sclerosis treatment: current best practice.

Published in:

2012

By:

Niino, Masaaki

Publication type:

Opinion

Update on the treatment options for multiple sclerosis.

Published in:

Expert Review of Clinical Immunology, 2010, v. 6, n. 1, p. 77, doi. 10.1586/ECI.09.75

By:

Niino, Masaaki;
Sasaki, Hidenao

Publication type:

Article

A new era in the treatment of multiple sclerosis.

Published in:

Medical Journal of Australia, 2015, v. 203, n. 3, p. 139, doi. 10.5694/mja14.01218

By:

Broadley, Simon A.;
Barnett, Michael H.;
Boggild, Mike;
Brew, Bruce J.;
Butzkueven, Helmut;
Heard, Robert;
Hodgkinson, Suzanne;
Kermode, Allan G.;
Lechner-Scott, Jeannette;
Macdonell, Richard AL;
Marriott, Mark;
Mason, Deborah F.;
Parratt, John;
Reddel, Stephen W.;
Shaw, Cameron P.;
Slee, Mark;
Spies, Judith M.;
Taylor, Bruce V.;
Carroll, William M.;
Kilpatrick, Trevor J.

Publication type:

Article

Multiple sclerosis and pregnancy - treatment considerations.

Published in:

Journal of Pre-Clinical & Clinical Research, 2020, v. 14, n. 4, p. 126, doi. 10.26444/jpccr/127671

By:

Kamieniak, Maciej Piotr;
Wolanin, Natalia;
Jarosz, Piotr;
Kobiałka, Izabela;
Kośmider, Kamil;
Petit, Véronique;
Rejdak, Konrad

Publication type:

Article

Natalizumab versus fingolimod and dimethyl fumarate in multiple sclerosis treatment.

Published in:

Annals of Clinical & Translational Neurology, 2019, v. 6, n. 2, p. 252, doi. 10.1002/acn3.700

By:

Vollmer, Brandi L.;
Nair, Kavita V.;
Sillau, Stefan;
Corboy, John R.;
Vollmer, Timothy;
Alvarez, Enrique

Publication type:

Article

Effectiveness and Safety of Dimethyl Fumarate Treatment in Relapsing Multiple Sclerosis Patients: Real-World Evidence.

Published in:

Neurology & Therapy, 2017, v. 6, n. 2, p. 189, doi. 10.1007/s40120-017-0080-x

By:

Alroughani, Raed;
Ahmed, Samar;
Behbehani, Raed;
Al-Hashel, Jasem

Publication type:

Article

Multiple sclerosis, disease modifying treatments and depression: a critical methodological review.

Published in:

Multiple Sclerosis (13524585), 2000, v. 6, n. 5, p. 343, doi. 10.1191/135245800678828012

By:

Feinstein, A.

Publication type:

Article

The Danish National Project of interferon-beta treatment in relapsing-remitting multiple sclerosis.

Published in:

Multiple Sclerosis (13524585), 2000, v. 6, n. 3, p. 172, doi. 10.1191/135245800701566034

By:

Koch-Henriksen, N.;
Soelberg Sørensen, P.

Publication type:

Article

Treatment adherence and patient retention in the first year of a Phase-III clinical trial for the treatment of multiple sclerosis.

Published in:

Multiple Sclerosis (13524585), 1999, v. 5, n. 3, p. 192, doi. 10.1191/135245899678846069

By:

Mohr, D.C.;
Goodkin, D.E.;
Masuoka, L.;
Dick, L.P.;
Russo, D.;
Eckhardt, J.;
Boudewyn, A.C.;
Bedell, L.

Publication type:

Article

Side effect profile and adherence to in the treatment of Multiple Sclerosis with interferon beta-1a.

Published in:

Multiple Sclerosis (13524585), 1998, v. 4, n. 6, p. 487, doi. 10.1191/135245898678845160

By:

Mohr, D.C.;
Likosky, W.;
Boudewyn, A.C.;
Marietta, P.;
Dwyer, P.;
van der Wende, J.;
Goodkin, D.E.

Publication type:

Article